Biomarkers in Parkinsonian Syndromes
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Multiple System Atrophy
Related studies linked through entity extraction aliases.
Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
- Status
- COMPLETED
- Phase
- PHASE2
Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
- Status
- COMPLETED
- Phase
- PHASE3
Natural History Study of Synucleinopathies
- Status
- RECRUITING
- Phase
- N/A
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Status
- RECRUITING
- Phase
- N/A
Magnetic Resonance Spectroscopy in Autonomic Failure
- Status
- TERMINATED
- Phase
- N/A
Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy
- Status
- COMPLETED
- Phase
- NA
Analysis of the Enteric Nervous System Using Colonic Biopsies
- Status
- COMPLETED
- Phase
- NA
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
- Status
- COMPLETED
- Phase
- N/A
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
- Status
- TERMINATED
- Phase
- PHASE1
Study of Rifampicin in Multiple System Atrophy
- Status
- TERMINATED
- Phase
- PHASE3
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Fluoxetine in Multiple System Atrophy Patients
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study
- Status
- COMPLETED
- Phase
- NA
The Role of Endothelin in the Supine Hypertension of Autonomic Failure
- Status
- WITHDRAWN
- Phase
- PHASE1
Nebivolol in the Supine Hypertension of Autonomic Failure
- Status
- COMPLETED
- Phase
- NA
Lithium in Multiple System Atrophy
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
- Status
- COMPLETED
- Phase
- PHASE2